Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination

Anaesthesia

Volumn 53, Issue 9, 1998, Pages 872-878

  Kim, K S ^a   Chun, Y S ^a   Chon, S U ^a   Suh, J K ^a  

^a Hanyang University College of Medicine   (South Korea)

Author keywords

Atracurium; Cisatracurium; Drug interactions; Mivacurium; Neuromuscular relaxants; Rocuronium; Vecuronium

Indexed keywords

ATRACURIUM; CISATRACURIUM; FENTANYL; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; PROPOFOL; ROCURONIUM; VECURONIUM;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MUSCLE TWITCH; MYOGRAPHY; NEUROMUSCULAR BLOCKING; RANDOMIZED CONTROLLED TRIAL; ULNAR NERVE; WRIST;

ADULT; ANDROSTANOLS; ANESTHESIA, GENERAL; ATRACURIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG SYNERGISM; FEMALE; HUMANS; ISOQUINOLINES; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; VECURONIUM BROMIDE;

EID: 0031691908     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.1998.00492.x     Document Type: Article

References (37)

1. Tsui D, Graham GG, Torda TA. The pharmacokinetics of atracurium isomers in vitro and in humans. Anesthesiology 1987; 67: 722-8.
2. Wastila WB, Maehr RB. The pharmacological profile of 51W89, the R, CIS-R', CIS isomer of atracurium in cats. Anesthesiology 1993; 79: A946.
3. Belmont MR, Lien CA, Quessy S, et al. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/ barbiturate anesthesia. Anesthesiology 1995; 82: 1139-45.
4. Lien CA, Belmont MR, Alochbalos A, et al. The cardiovascular effects and histamine releasing properties of 51W89 in patients receiving nitrous oxide/opioid/ barbiturate anesthesia. Anesthesiology 1995; 82: 1131-8.
5. Ali HH, Savarese JJ, Embree PB, et al. Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium. British Journal of Anaesthesia 1988; 61: 541-6.
6. Savarese JJ, Ali HH, Basta SJ, et al. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug. Anesthesiology 1988; 68: 723-32.
7. Fahey MR, Morris RB, Miller RD, Sohn YJ, Cronnelly R, Gencarelli P. Clinical pharmacology of ORG NC (Norcuron): a new nondepolarizing muscle relaxant. Anesthesiology 1981; 55: 6-11.
8. Wierda JMKH, De Wit APM, Kuizenga K, Agoston S. Clinical observations on the neuromuscular blocking action of ORG 9426, a new steroidal nondepolarizing agent. British Journal of Anaesthesia 1990; 64: 521-3.
9. Naguib N, Abdulatif M, Al-Ghamdi A, et al. Interactions between mivacurium and atracurium. British Journal of Anaesthesia 1994; 73: 484-9.
10. Jalkanen L, Meretoja OA, Taivainen T, Brandom BW, Dayal B. Synergism between atracurium and mivacurium compared with that between vecuronium and mivacurium. Anesthesia and Analgesia 1994; 79: 998-1002.
11. Brandom BW, Meretoja OA. Dose-response calculation revisited. Anesthesia and Analgesia 1994; 78: 608-9.
12. Finney DJ. Statistical Methods In Biological Assay, 2nd edn. London: Griffin, 1971; 21-57.
13. Tallarida RJ, Porreca F, Cowan A. Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sciences 1989; 45: 947-61.
14. Berenbaum MC. What is synergy? Pharmacological Reviews 1989; 41: 93-141.
15. Naguib M, Abdulatif M. Isobolographic and dose-response analysis of the interaction between pipecuronium and vecuronium. British Journal of Anaesthesia 1993; 71: 556-60.
16. Naguib M, Samarkandi AH, Bakhamees HS, Magboul MA, El-Bakry AK. Comparative potency of steroidal neuromuscular blocking drugs and isobolographic analysis of the interaction between rocuronium and other amino-steroids. British Journal of Anaesthesia 1995; 75: 37-42.
17. Kim KS, Na DJ, Chon SU. Interactions between suxamethonium and mivacurium or atracurium. British Journal of Anaesthesia 1996; 77: 612-6.
18. Kim KS, Shim JC, Kim DW. Interactions between mivacurium and pancuronium. British Journal of Anaesthesia 1997; 79: 19-23.
19. Bernbaum MC. Synergy, additivism and antagonism in immunosuppression. Journal of Clinical and Experimental Immunology 1977; 28: 1-18.
20. 2-opioid anesthesia. Anesthesia and Analgesia 1996; 83: 823-9.
21. Rautoma P, Erkola O, Meretoja OA. Synergism between mivacurium and pancuronium in adults. Acta Anaesthesiologica Scandinavica 1995; 39: 733-7.
22. Gramstad L, Lilleaasen P. Dose-response relation for atracurium, Org NC 45 and pancuronium. British Journal of Anaesthesia 1982; 54: 647-51.
23. Sokoll MD, Gergis SD, Mehta M, Ali NM, Lineberry C. Safety and efficacy of atracurium (BW33A) in surgical patients receiving balanced or isoflurane anesthesia. Anesthesiology 1983; 58: 450-5.
24. Naguib M. Neuromuscular effects of rocuronium bromide and mivacurium chloride administered alone and in combination. Anesthesiology 1994; 81: 388-95.
25. Diefenbach C, Nigrovic V, Mellinghoff H, Buzello W. Muscle relaxants. New substances and neuromuscular monitoring. Anaesthesist 1997; 46: 3-13.
26. Waud BE, Waud DR. Quantitative examination of interaction of competitive neuromuscular blocking agents on the indirectly elicited muscle twitch. Anesthesiology 1984; 61: 420-7.
27. Chapple DJ, Clark JS, Hughes R. Interaction between atracurium and drugs used in anaesthesia. British Journal of Anaesthesia 1983; 55: 17S-22S.
28. Ghoneim MM, Urgena RB, Dretchen K, Long JP. The interaction between d-tubocurarine and gallamine during halothane anaesthesia. Canadian Anaesthetists Society Journal 1972; 19: 66-74.
29. Lebowitz PW, Ramsey FM, Savarese JJ, Ali HH. Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine. Anesthsia and Analgesia 1980; 59: 604-9.
30. Pollard BJ, Jones RM. Interactions between tubocurarine, pancuronium and alcuronium demonstrated in the rat phrenic nerve-hemidiaphragm preparation. British Journal of Anaesthesia 1983; 55: 1127-30.
31. Meretoja OA, Brandom BW, Taivainen T, Jalkanen L. Synergism between atracurium and vecuronium in children. British Journal of Anaesthesia 1993; 71: 440-2.
32. Martyn JAJ, Leibel WS, Matteo RS. Competitive nonspecific binding does not explain the potentiating effects of muscle relaxants combinations. Anesthesia and Analgesia 1983; 62: 160-3.
33. Pedersen SE, Papineni RV Interaction of d-tubocurarine analogs with the Torpedo nicotinic acetylcholine receptor. Methylation and stereoisomerization affect site-selective competitive binding and binding to the noncompetitive site. The Journal of Biological Chemistry 1995; 270: 31141-50.
34. Van der Spek AF, Zupan JT, Pollard BJ, Schork MA. Interactions of vecuronium and atracurium in an in vitro nerve-muscle preparation. Anesthesia and Analgesia 1988; 67: 240-6.
35. Gessner PK. Isobolographic analysis of interactions: an update on applications and utility. Toxicology 1995; 105: 161-79.
36. Carter WH Jr. Relating isobolograms to response surfaces. Toxicology 1995; 105: 181-8.
37. Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation 1983; 22: 27-55.